BioNTech (BNTX) PT Lowered to $110 at Morgan Stanley
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
- Wall St set for muted open as tech stocks take a breather
- Oil steadies on rise in Middle East crude exports and G7 stocks release
- Intel stock slides as TSMC explores Terafab tie-up, analyst flags share losses
- Five things to watch in markets in the week ahead
- Citi sees room for further equities upside in 2027 on resilient earnings growth
Tweet
Share
E-mailGet Alerts BNTX Hot Sheet
Price: $96.90 --0%
Rating Summary:
16 Buy, 7 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 10 | Down: 12 | New: 24
Rating Summary:
16 Buy, 7 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 10 | Down: 12 | New: 24
Join SI Premium – FREE
Morgan Stanley analyst Matthew Harrison lowered the price target on BioNTech (NASDAQ: BNTX) to $110.00 (from $116.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- S&P Global (SPGI) PT Lowered to $531 at Mizuho
- DTE Energy (DTE) PT Raised to $134 at BMO Capital
- Sherwin-Williams (SHW) PT Lowered to $363 at UBS
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
